Biotechnology VALUE FUND L P, Director Other at Kymera Therapeutics, Inc. (KYMR), bought 544,166 shares at $47.00 ($25.6M) on 2021-07-01, disclosed to the SEC on 2021-07-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.00 | 27,458 | $1.3M | 5.0% |
| 2 | $47.00 | 211,711 | $10.0M | 38.9% |
| 3 | $47.00 | 304,997 | $14.3M | 56.0% |
| Total | $47.00 avg | 544,166 | $25.6M | 100% |
| Filing → |
| KYMR | BUY | 2022-05-24 | $141K | — | Filing → |
| OLMA | BUY | 2021-12-02 | $13.9M | — | Filing → |
| RAIN | BUY | 2021-07-06 | $15.7M | — | Filing → |